Exec Chairman of the Board of Ionis Pharmaceuticals Inc (NASDAQ:IONS), Crooke Stanley T, sells 2,590 shares worth $131,650

According to Ionis Pharmaceuticals Inc's most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Nov 25 07:04 PM, company Exec Chairman of the Board, Crooke Stanley T disclosed selling 2,590 shares at a cost of $50.83. At the time of this transaction (Nov 24), this trade was worth $131,650 in total. As of Nov 24, Crooke Stanley T now owns 2,021 shares in total worth about $101,535.04000000001.

For the last few recent trades made by Ionis Pharmaceuticals Inc (NASDAQ:IONS) Exec Chairman of the Board, Crooke Stanley T, we have the following information:

  1. SEC Form 4 filing: Nov 23: Sold 11,600 shares at the rate of $50.11 per share. Total worth of this trade was $581,276. Total number of shares owned as of Nov 23 were 2,021
  2. SEC Form 4 filing: Nov 23: Sold 500 shares at the rate of $50.00 per share. Total worth of this trade was $25,000. Total number of shares owned as of Nov 23 were 1,581
  3. SEC Form 4 filing: Sep 21: Sold 2,000 shares at the rate of $50.18 per share. Total worth of this trade was $100,360. Total number of shares owned as of Sep 21 were 1,581
Posted by on Thursday November 26 2020, 2:05 PM EDT. All trademarks acknowledged. Filed under Business, Stocks. Comments and Trackbacks closed. Follow responses: RSS 2.0

Comments are closed

Featured Press Releases

Log in